Search

everythinglearnresearchcommunity

for

Search:↓

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Upadacitinib may effectively treat resistant lichen planopilaris.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Targeting NETs may help reduce fibrosis in Crohn's disease.

TICE salvage chemotherapy is effective for treating germ-cell tumors with poor prognosis.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Imuvert can prevent some chemotherapy-induced hair loss.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.